Multiple Myeloma Clinical Trials in Salamanca

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +146 more
2021-10-14
Oct 14, 2021
J
Recruiting
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +12 more
2021-10-07
Oct 7, 2021
J
Recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +112 more
2021-10-07
Oct 7, 2021
C
Recruiting
  • Multiple Myeloma
  • CTX120
  • Chicago, Illinois
  • +9 more
2021-10-07
Oct 7, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Southington, Connecticut
  • +63 more
2021-10-07
Oct 7, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
2021-10-07
Oct 7, 2021
G
Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +135 more
2021-10-01
Oct 1, 2021
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2021-09-30
Sep 30, 2021
O
Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +108 more
2021-09-27
Sep 27, 2021
K
Active, not recruiting
  • Multiple Myeloma
  • Plantation, Florida
  • +156 more
2021-09-24
Sep 24, 2021